ENALAPRILAT INJECTION USP
Google image searchProduct monograph
Active ingredient
enalaprilat, 1.25 MG/ML
DIN: 02388499
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 22-MAY-2024
ATC:
- C09 — AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (ATC, ATC/DDD, )
- C09A — ACE INHIBITORS, PLAIN (ATC, ATC/DDD)
- C09AA — ACE inhibitors, plain (ATC, ATC/DDD)
- C09AA02 — ENALAPRIL (ATC/DDD)
Reference brand drug: Vasotec
Pharmaceutical standard: USP
